Association Between Statin Use Prior to Admission and Lower Coronavirus Disease 2019 (COVID-19) Severity in Patients With Cardiovascular Disease or Risk Factors

Autor: Misaki Hasegawa, Shunsuke Kuroda, Taishi Yonetsu, Takuya Kishi, Shingo Matsumoto, Takeshi Kitai, Kazuki Aihara, Issei Komuro, Sho Torii, Yuya Matsue, Takahide Sano, Ken-ichi Hirata, Yuji Ikari, Shun Kohsaka, Koichi Node
Rok vydání: 2021
Předmět:
Zdroj: Circulation Journal. 85:939-943
ISSN: 1347-4820
1346-9843
DOI: 10.1253/circj.cj-21-0087
Popis: BACKGROUND: Cardiovascular diseases and/or risk factors (CVDRF) have been reported as risk factors for severe coronavirus disease 2019 (COVID-19).Methods and Results:In total, we selected 693 patients with CVDRF from the CLAVIS-COVID database of 1,518 cases in Japan. The mean age was 68 years (35% females). Statin use was reported by 31% patients at admission. Statin users exhibited lower incidence of extracorporeal membrane oxygenation (ECMO) insertion (1.4% vs. 4.6%, odds ratio [OR]: 0.295, P=0.037) and septic shock (1.4% vs. 6.5%, OR: 0.205, P=0.004) despite having more comorbidities such as diabetes mellitus. CONCLUSIONS: This study suggests the potential benefits of statins use against COVID-19.
Databáze: OpenAIRE